Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 May;144(5):569-73.
doi: 10.1016/j.jpeds.2004.01.025.

Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation

Satkiran S Grewal  1 , Elsa G Shapiro, William Krivit, Lawrence Charnas, Lawrence A Lockman, Kathleen A Delaney, Stella M Davies, David A Wenger, Frank L Rimell, Susan Abel, Alfred C Grovas, Paul J Orchard, John E Wagner, Charles Peters
Affiliations
Clinical Trial

Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation

Satkiran S Grewal et al. J Pediatr. 2004 May.

Abstract

Objectives: To study the efficacy of hematopoietic stem cell transplantation (HCT) for ameliorating the clinical manifestations of alpha-mannosidosis.

Study design: Four patients with alpha-mannosidosis underwent allogeneic HCT at the University of Minnesota. Diagnosis was established by assay of leukocyte alpha-mannosidase activity level. Physical features, donor engraftment, leukocyte alpha-mannosidase activity, neuropsychologic function, and hearing were monitored before and after transplantation, with follow-up ranging from 1 to 6 years.

Results: All 4 patients showed slowing of their neurocognitive development and sensorineural hearing loss before HCT. All patients are alive, with normalization of leukocyte enzyme activity after HCT. Intellectual function has stabilized, with improvement in adaptive skills and verbal memory function in 3 of 4 patients. Hearing has improved to normal or near normal for speech frequencies in 3 patients. No new skeletal abnormalities have developed.

Conclusions: HCT can halt the progressive cognitive loss in patients with alpha-mannosidosis. Early diagnosis and treatment with HCT is critical for optimal results.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types